Breaking News

Financial Report: PAREXEL

May 1, 2013

Revenues up 27% in the quarter

PAREXEL

3Q Revenues: $523.5 million (+27%)

3Q Earnings: $29.5 million (+29%)

YTD Revenues: $1.5 billion (+27%)

YTD Earnings: $65.9 million (+45%)

Comments: Clinical Research Services (CRS) revenues were $342.4 million in the quarter, up 30%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $50.6 million, up 17%. Perceptive Informatics (PI) revenues were $61.5 million, up 25%.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks